CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件                        
已选(0)清除 条数/页:   排序方式:
Phase I study of single-agent pyrotinib, a novel irreversible pan-ErbB receptor tyrosine kinase inhibitor, in patients with ErbB2+metastatic breast cancer 会议论文
作者:  Xu, B.;  Ma, F.;  Chen, S.;  Li, Q.;  Yang, F.
收藏  |  浏览/下载:12/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace